MENU
PRME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Prime Medicine (PRME) Ownership - Who owns Prime Medicine?
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing... Show more
Profile
Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
960.9M
P/E Ratio
N/A
Total Cash
101.75M
Projected Growth
N/A
Total Debt
119.74M
Revenue
4.96M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
PRME
Capitalization
961M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
102M
Total Cash/Share
0.57
Total Debt
120M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
4.96M
ROE
N/A
Book Value
60.9M
P/B Ratio
15.80
Cash Flow
N/A
Earnings
-1.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
3.56
Current Revenue Per Employee
5210.28
Dividends Per Share - Security
N/A
EBITDA
-197.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-73.98
Shares Held By Institutions
649M
Shares Outstanding - Current
178M
Total Liabilities
218M
Total Volume MTD
N/A
Value
-1
Gain YTD
84.589
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRME showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com